Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:ONON
NYSE:ONONLuxury

Aecon And 2 US Onshoring Stocks With Backlog And Margin Focus

Tariffs on Brazilian goods have pushed more of the supply chain conversation back to North America, and that has put renewed attention on stocks tied to U.S. domestic manufacturing and onshoring. For investors watching the ripple effects of higher import costs, factory reshoring, and companies rethinking where they source machinery, equipment, and consumer goods, this shift may create both opportunities and risks. This article walks through 3 stocks from our U.S. Domestic Manufacturing and...
ASX:LIN
ASX:LINMetals and Mining

3 Australian Resource Stocks With High Insider Ownership And Growth Risk

With inflation signals flickering across regions, central banks cautious on rates, and consumer sentiment mixed, many investors are looking for companies that can grow through different cycles and where insiders have meaningful skin in the game. The Fast Growing Stocks With High Insider Ownership screener focuses on businesses that combine solid growth potential with management and analyst optimism, which can help align executive incentives with shareholder outcomes. In this article you will...
NasdaqGS:EWTX
NasdaqGS:EWTXPharmaceuticals

Edgewise Therapeutics (EWTX) Stock Looks Fully Priced After Phase 2 HCM Progress

Edgewise Therapeutics (EWTX) drew fresh investor attention after reporting favorable Phase 2 Part D CIRRUS-HCM data for EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy, with results supporting progression to Phase 3 development. See our latest analysis for Edgewise Therapeutics. The Phase 2 CIRRUS-HCM update lands at a time when Edgewise Therapeutics has already seen strong momentum, with a 1-month share price return of 12.57% and a year-to-date share price return of...
TSX:HPS.A
TSX:HPS.AElectrical

Hammond Power Solutions (TSX:HPS.A) Stock Could Be 3.4% Undervalued After Index Addition

Hammond Power Solutions (TSX:HPS.A) has been added to the S&P/TSX Capped Composite Index. This type of inclusion often attracts attention from index-tracking funds and can reshape how investors look at the stock. See our latest analysis for Hammond Power Solutions. Recent share price momentum has been strong, with Hammond Power Solutions posting a 1 day share price return of 3.13%, a 90 day share price return of 77.23%, and a year to date share price return of 115.59%. The 1 year total...
NYSE:BIRK
NYSE:BIRKLuxury

Does Birkenstock’s Profitability Momentum and Supportive Sentiment Shift the Bull Case For BIRK?

In recent days, Birkenstock Holding plc reported year-over-year increases in revenue and net profit alongside high operating efficiency and a stable financial health score. At the same time, a generally favorable analyst stance and mixed but leaning-positive technical indicators have reinforced investor attention on Birkenstock within the consumer cyclical sector. Next, we will examine how Birkenstock’s stronger profitability profile may influence its broader investment narrative for...
TSX:CM
TSX:CMBanks

How CIBC’s ETF Closures and Fund Risk Shift Will Impact Canadian Imperial Bank of Commerce (TSX:CM) Investors

Earlier in June 2026, Canadian Imperial Bank of Commerce announced the upcoming termination of certain ETF series and a change to a mutual fund’s risk rating after filing related SEC documents, signaling a reshaping of its investment product lineup. These adjustments may matter for investors because they touch on how CIBC is recalibrating its asset and wealth management offerings in response to client demand and regulatory expectations. We’ll now examine how CIBC’s ETF terminations and...
SEHK:867
SEHK:867Pharmaceuticals

How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors

China Medical System Holdings announced that its New Drug Application for Silevimig Injection, a fully human bispecific antibody for passive immunization after rabies exposure, was approved by China’s National Medical Products Administration on 22 June 2026, and the company obtained the drug registration certificate. This approval introduces the world’s first dual-epitope rabies bispecific antibody, adding an eighth commercialized innovative drug to the group’s portfolio and enhancing its...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

3 Consumer Stocks With Earnings Growth And Funding Risk

Geopolitics, central bank shifts, and a surprise box office hit are all feeding into the same question for investors right now: which consumer-focused stocks might be better positioned for the next phase of market sentiment and which might be more exposed to the risks. This article looks at how easing Middle East tensions, fresh signals from the Federal Reserve after Alan Greenspan’s passing, political change in the U.K., and the strong “Toy Story 5” performance could matter for larger...
OB:HAFNI
OB:HAFNIOil and Gas

Hafnia (OB:HAFNI) Stock Could Be 17.5% Undervalued After Downgrade And Q1 Earnings

Pareto analyst Eirik Haavaldsen’s downgrade of Hafnia (OB:HAFNI) to Hold, coming right after the company’s first quarter 2026 earnings call, has sharpened investor focus on how geopolitical disruptions and recent results intersect. See our latest analysis for Hafnia. Hafnia’s share price has eased over the past month, with a 30 day share price return of down 16%, yet the year to date share price return of 31.9% and 1 year total shareholder return of 35.9% still point to momentum built over a...
NYSE:MOH
NYSE:MOHHealthcare

3 US Defensive Stocks With Strong Margins And Essential Healthcare Demand

Markets are watching the Supreme Court and the Federal Reserve almost as closely as earnings reports right now, as questions over central bank independence and possible political pressure on monetary policy add a fresh layer of risk for portfolios. When trust in the Fed is in focus, many investors look again at large U.S. defensive stocks that may offer relatively steadier business profiles if volatility picks up. This article explains how that backdrop could influence your positioning and...
NYSE:LXP
NYSE:LXPIndustrial REITs

Rising Institutional Stakes and Fresh Dividends Might Change The Case For Investing In LXP Industrial Trust (LXP)

LXP Industrial Trust recently declared a regular common share dividend of US$0.70 per share for the June 2026 quarter and a US$0.8125 Series C preferred dividend, both payable to shareholders of record on their respective cut-off dates. Alongside these payouts, institutional ownership has risen to a very large proportion of the share base, with major investors like BlackRock and PGIM Fixed Income increasing their holdings, coinciding with fresh positive sector commentary from Raymond...
NasdaqGS:FCFS
NasdaqGS:FCFSConsumer Finance

FirstCash Holdings (FCFS) Stock Can Its Valuation Hold Up After Strong Quarterly Results

Fresh attention is turning to FirstCash Holdings (FCFS) after recent quarterly results showed strong year-over-year revenue and profit growth, alongside high institutional ownership and technical indicators that point to improving sentiment in the stock. See our latest analysis for FirstCash Holdings. At a share price of $227.05, FirstCash Holdings has logged a 15.65% 90 day share price return and a 44.82% year to date share price return, contributing to a 76.19% 1 year total shareholder...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Solutions (VIAV) Stock Could Be 26.8% Undervalued After PCI SIG Testing Win

Viavi Solutions (VIAV) is back on investor radars after its Xgig PCIe 6.0 testing platform secured Gold Suite acceptance from PCI-SIG, alongside a fresh TETRA MS simulator upgrade for its CX300 service monitor. See our latest analysis for Viavi Solutions. The recent product news arrives after a sharp pullback, with Viavi Solutions’ share price down 3.20% over one day and 12.73% over seven days, yet still showing a 31.25% 90 day share price return and a very large 1 year total shareholder...
NYSE:ESI
NYSE:ESIChemicals

Element Solutions (ESI) Stock Could Be 3% Undervalued as AI Demand Lifts the Narrative

Element Solutions (ESI) has drawn investor attention after a recent stretch of strong share performance, with the stock up 13% over the past month and 36% over the past 3 months. See our latest analysis for Element Solutions. Looking beyond the recent rally, Element Solutions has delivered a 77.22% year to date share price return. Its 1 year total shareholder return of 111.52% and 3 year total shareholder return of 158.26% point to strong, sustained momentum. If you are reviewing Element...
TSX:POW
TSX:POWInsurance

3 Insurance Stocks For Dividend Growth And Balance Sheet Strength

With the Federal Reserve signaling possible rate hikes and markets reacting to every economic data release, income-focused investors are paying closer attention to dividend growth stocks that appear built to handle more turbulence. This article looks at how recent Fed commentary, trade talks and geopolitical risks could affect a select group of dividend growth companies, all filtered for consistent payouts, room for increases and solid balance sheet health. Ahead, you will see 3 stocks from...
NYSE:SXI
NYSE:SXIMachinery

Standex International (SXI) Stock Could Be 8.4% Overvalued After Analyst Backing And Strong Results

Standex International (SXI) is back on investors’ radar after a respected William Blair analyst reaffirmed a positive rating, alongside rising institutional ownership, bullish technical signals, and strong year-over-year revenue and profit growth. See our latest analysis for Standex International. The recent 6.56% 1 day share price return, on top of a 23.20% 30 day share price return and 40.16% year to date share price return, reflects strong momentum around Standex International as investors...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

What Neurocrine Biosciences (NBIX)'s New CRENESSITY CAH Data Means For Shareholders

Earlier in June 2026, Neurocrine Biosciences reported new data at ENDO 2026 showing CRENESSITY (crinecerfont) delivered strong hormonal control and glucocorticoid-sparing benefits in classic congenital adrenal hyperplasia, including the rarer 11ß-hydroxylase deficiency subtype. The combination of long-term Phase 3 outcomes and first-of-its-kind real-world evidence in this understudied CAH subgroup adds depth to CRENESSITY’s profile in rare endocrine care. Next, we’ll consider how this new...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Does Gen Digital’s Upgraded 2026 Outlook Recast the Bull Case for GEN?

Earlier in 2026, Gen Digital reported strong Q3 fiscal 2026 earnings and raised its full-year guidance for revenue and adjusted earnings per share, citing improved operating performance. This guidance upgrade highlights how management’s confidence in the core cyber safety and AI-enhanced security platform could influence expectations around the company’s longer-term profitability profile. We’ll now examine how the upgraded full-year guidance interacts with Gen Digital’s existing investment...
NasdaqGS:FIBK
NasdaqGS:FIBKBanks

3 US Bank Stocks With High Dividend Yields And Profit Margins

Rising geopolitical tension in the Middle East, a cautious Federal Reserve, and softer pre market trading have put income focused portfolios under fresh scrutiny. When U.S. stock futures soften and crude trades lower despite regional risks, reliable dividend cheques can feel more reassuring than potential price swings. This article looks at three high dividend yield stocks from our screener that appear closely tied to these latest headlines. You will see how the same mix of Fed uncertainty...
NYSE:SGI
NYSE:SGIConsumer Durables

Somnigroup International (SGI) Stock Could Be 22.8% Undervalued After Its Rebrand

Somnigroup International (SGI) has drawn fresh attention after its recent rebranding from Tempur Sealy International, prompting investors to reassess the bedding company's fundamentals, earnings profile, and current share performance. See our latest analysis for Somnigroup International. At a share price of $75.10, Somnigroup International has seen a 12.27% 1 month share price return, while the year to date share price return is down 15.37%, set against a 14.50% 1 year total shareholder...
ENXTPA:ETL
ENXTPA:ETLMedia

Does Eutelsat (ENXTPA:ETL) Winning the CENTAURE LEO Deal Redefine Its Government-Connectivity Edge?

In June 2026, Eutelsat Communications S.A. announced it had signed the CENTAURE contract via France’s defence procurement agency, the DGA, a roughly €350 million call-off under the €1.00 billion NEXUS framework to provide LEO satellite capacity and enhance the security of its OneWeb services for the French Armed Forces over up to eight years. This agreement reinforces Eutelsat’s role as a European provider of secure low-latency LEO connectivity for government and defence users, supporting...
ASX:AFI
ASX:AFICapital Markets

Does AFIC’s Fully Franked Special Dividend Reveal a Deeper Capital Allocation Shift for ASX:AFI?

Australian Foundation Investment Company Limited has announced, in June 2026, a fully franked final dividend of A$0.145 per share and a fully franked special dividend of A$0.025 per share for the year ended 30 June 2026, both subject to market conditions and no adverse shocks. The combination of a regular final payout and an additional special dividend highlights management’s focus on distributing income to shareholders through fully franked returns. Next, we will examine how the fully...
NYSE:EL
NYSE:ELPersonal Products

Is Estée Lauder (EL) Quietly Rebalancing Between AI Fragrance Tools and In‑House Production Capacity?

In recent weeks, Estée Lauder Companies and Jo Malone London launched Scent Scanner, an AI-powered Pinterest tool for personalized fragrance recommendations, while Estée Lauder also expanded UK home fragrance manufacturing and ended merger talks with Puig. Together, these moves highlight how Estée Lauder is pairing AI-led consumer engagement with greater in-house production, potentially reshaping how it allocates resources between digital innovation and physical capacity. Next, we'll examine...
NYSE:CCI
NYSE:CCISpecialized REITs

Crown Castle (CCI) Stock Could Be 17.2% Undervalued After Its Recent Pullback

Recent Performance Puts Crown Castle Under Closer Scrutiny Crown Castle (CCI) has drawn fresh attention after a period where the stock declined around 10% over the past month but rose roughly 4% over the past 3 months, prompting investors to reassess expectations. See our latest analysis for Crown Castle. Over the past year, Crown Castle’s share price return has been weak, with the stock down year to date and the 1 year total shareholder return falling 16.13%, while the recent 7 day and 30...